AptaBio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	237,951	251,341	171,234	201,805	237,483
Market Cap Growth	23.63%	46.78%	-15.15%	-15.02%	-
Enterprise Value	225,183	240,559	146,945	152,862	-
Last Close Price	8470.00	9350.00	6370.00	9050.00	10650.00
Forward PE	-	78.10	78.10	78.10	78.10
PS Ratio	64.35	67.97	50.95	623.11	4911.46
PB Ratio	5.04	5.33	3.16	3.29	4.54
P/TBV Ratio	5.16	5.45	3.16	3.32	4.54
EV/Sales Ratio	60.89	65.05	43.72	471.99	-
Debt / Equity Ratio	0.09	0.09	0.14	0.23	0.01
Net Debt / Equity Ratio	-0.27	-0.27	-0.44	-0.63	-0.32
Net Debt / EBITDA Ratio	0.85	0.85	1.19	2.38	1.85
Net Debt / FCF Ratio	0.83	0.83	1.94	2.52	2.11
Asset Turnover	0.05	0.05	0.04	0.00	-
Inventory Turnover	5.75	5.75	-	-	-
Quick Ratio	1.84	1.84	1.67	65.10	16.58
Current Ratio	2.61	2.61	1.79	70.27	19.63
Return on Equity (ROE)	-32.25%	-32.25%	-50.84%	-21.21%	-
Return on Assets (ROA)	-14.13%	-14.13%	-15.24%	-14.22%	-
Return on Capital Employed (ROCE)	-30.90%	-30.90%	-35.80%	-18.40%	-17.30%
Earnings Yield	-6.87%	-6.50%	-17.16%	-5.98%	-4.45%
FCF Yield	-6.44%	-6.10%	-7.24%	-7.65%	-3.32%
Buyback Yield / Dilution	-14.40%	-14.40%	-5.57%	-0.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.